Plasma KL-6 as a Potential Biomarker for Bronchopulmonary Dysplasia in Preterm Infants.
Petya RadulovaMargaritka BonchevaGencho NachevBoriana SlanchevaVioleta DimitrovaPublished in: Critical care research and practice (2024)
KL-6 could be a useful screening biomarker for early detection of infants at increased risk for developing BPD.